<SEC-DOCUMENT>0001062993-23-023268-index.html : 20231229 <SEC-HEADER>0001062993-23-023268.hdr.sgml : 20231229 <ACCEPTANCE-DATETIME>20231229075411 ACCESSION NUMBER: 0001062993-23-023268 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 GROUP MEMBERS: BOAZ R. WEINSTEIN GROUP MEMBERS: SABA CAPITAL MANAGEMENT GP, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: abrdn Life Sciences Investors CENTRAL INDEX KEY: 0000884121 ORGANIZATION NAME: IRS NUMBER: 043147016 STATE OF INCORPORATION: PA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-48561 FILM NUMBER: 231524310 BUSINESS ADDRESS: STREET 1: 1900 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 6177728515 MAIL ADDRESS: STREET 1: 1900 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: TEKLA LIFE SCIENCES INVESTORS DATE OF NAME CHANGE: 20141015 FORMER COMPANY: FORMER CONFORMED NAME: H&Q LIFE SCIENCES INVESTORS DATE OF NAME CHANGE: 19920929 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Saba Capital Management, L.P. CENTRAL INDEX KEY: 0001510281 ORGANIZATION NAME: IRS NUMBER: 800361690 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: 212-542-4635 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D <SEQUENCE>1 <FILENAME>formsc13d.htm <DESCRIPTION>FORM SC 13D <TEXT> Document 1 - file: formsc13d.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1 <SEQUENCE>2 <FILENAME>exhibit1.htm <DESCRIPTION>EXHIBIT 1 <TEXT> Document 2 - file: exhibit1.htm
</DOCUMENT> </SEC-DOCUMENT>